| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |